alexa MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Clinical Sciences

Clinical Sciences

Cardiovascular Pharmacology: Open Access

Author(s): Yongchao Wang, Jianpeng Teoh, Kyoungmi Park, Yaoping Tang, Siva Krothapalli

Abstract Share this page

Cardiac disease is a leading cause of morbidity and mortality worldwide and is likely to remain a major challenge into the 21st century because of population aging and global epidemic of obesity. Primary prevention is the most effective way to reduce the disease burden but has produced limited success due to challenges in its societal implementation and individual compliance. The alternative, complementary approach could be secondary prevention to slow the progress of disease in its earliest stages, and biomarkers can contribute to the success by improving risk stratification and also providing surrogate endpoints to enable more rapid performance of clinical studies to develop tailored treatment. MicroRNAs (miRs) are small, non-coding RNA molecules that play important regulatory roles in gene expression. MiRs are generally considered to act as intracellular mediators essential for normal cardiac function and their deregulated expression profiles have often been associated with cardiovascular diseases. Recent discoveries demonstrated that miRs circulate in a stable form through many body fluids including blood, opening the possibility that circulating miRs can serve as diagnostic, prognostic or predictive markers for a variety of cardiovascular diseases including acute myocardial infarction and heart failure. Given that each specified miR has its unique sets of target genes, development of miR biomarkers together with identification of the target mRNAs may have utility for pharmacological intervention. This review summarizes the literature on miRs as cardiac biomarkers, followed by a summary of recent patents that utilize miRs as diagnostic markers of heart disease.

  • To read the full article Visit
  • Open Access
This article was published in Recent Patents on Biomarkers and referenced in Cardiovascular Pharmacology: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version